GME Overzicht aandelen
Geratherm Medical AG is een medisch technologiebedrijf in Duitsland.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 3/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 3/6 |
| Dividenden | 1/6 |
Geratherm Medical AG Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | €3.24 |
| 52 Week Hoogtepunt | €6.00 |
| 52 Week Laag | €3.14 |
| Bèta | 0.026 |
| 11 maand verandering | -13.83% |
| 3 maanden verandering | -13.83% |
| 1 Jaar Verandering | -41.62% |
| 33 jaar verandering | -65.53% |
| 5 jaar verandering | -56.80% |
| Verandering sinds IPO | -66.60% |
Recent nieuws en updates
Investors Don't See Light At End Of Geratherm Medical AG's (ETR:GME) Tunnel And Push Stock Down 26%
Oct 16
The Market Lifts Geratherm Medical AG (ETR:GME) Shares 28% But It Can Do More
Aug 21Recent updates
Investors Don't See Light At End Of Geratherm Medical AG's (ETR:GME) Tunnel And Push Stock Down 26%
Oct 16The Market Lifts Geratherm Medical AG (ETR:GME) Shares 28% But It Can Do More
Aug 21We Think Geratherm Medical's (ETR:GME) Solid Earnings Are Understated
Jun 27Geratherm Medical (ETR:GME) Is Reducing Its Dividend To €0.12
Apr 10Is Geratherm Medical (ETR:GME) A Risky Investment?
Mar 02Geratherm Medical (ETR:GME) Has Some Way To Go To Become A Multi-Bagger
May 08Is Geratherm Medical AG's (ETR:GME) 2.1% Dividend Sustainable?
Apr 19Is Geratherm Medical (ETR:GME) A Risky Investment?
Mar 01Returns On Capital Tell Us A Lot About Geratherm Medical (ETR:GME)
Jan 22
Consider This Before Buying Geratherm Medical AG (ETR:GME) For The 2.3% Dividend
Jan 04Update: Geratherm Medical (ETR:GME) Stock Gained 22% In The Last Year
Dec 17We Think Geratherm Medical (ETR:GME) Can Stay On Top Of Its Debt
Nov 29Rendement voor aandeelhouders
| GME | DE Medical Equipment | DE Markt | |
|---|---|---|---|
| 7D | -4.1% | -2.7% | -1.8% |
| 1Y | -41.6% | -2.7% | 13.6% |
Rendement versus industrie: GME underperformed the German Medical Equipment industry which returned -3.5% over the past year.
Rendement versus markt: GME underperformed the German Market which returned 13.2% over the past year.
Prijsvolatiliteit
| GME volatility | |
|---|---|
| GME Average Weekly Movement | 10.2% |
| Medical Equipment Industry Average Movement | 5.3% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stabiele aandelenkoers: GME's share price has been volatile over the past 3 months compared to the German market.
Volatiliteit in de loop van de tijd: GME's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1990 | 179 | Christian Frick | www.geratherm.com |
Geratherm Medical AG is een medisch-technologisch bedrijf in Duitsland. Het is actief via de segmenten Healthcare Diagnostic, Respiratory, Cardio/Stroke en Medical Warming Systems. Het Healthcare Diagnostic segment levert klinische thermometers en bloeddrukmeters.
Geratherm Medical AG Samenvatting
| GME fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | €17.43m |
| Inkomsten(TTM) | -€830.50k |
| Inkomsten(TTM) | €18.31m |
1.0x
P/S-verhouding-21.0x
Koers/WinstverhoudingIs GME overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| GME resultatenrekening (TTM) | |
|---|---|
| Inkomsten | €18.31m |
| Kosten van inkomsten | €4.91m |
| Brutowinst | €13.39m |
| Overige uitgaven | €14.22m |
| Inkomsten | -€830.50k |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.15 |
| Brutomarge | 73.16% |
| Nettowinstmarge | -4.54% |
| Schuld/Eigen Vermogen Verhouding | 30.8% |
Hoe presteerde GME op de lange termijn?
Bekijk historische prestaties en vergelijking